Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Onakpoya, I, Heneghan, C, Aronson, J
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	BioMed Central 2016

Ижил төстэй зүйлс

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
-н: Onakpoya, IJ, зэрэг
Хэвлэсэн: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2016)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
-н: Onakpoya, I
Хэвлэсэн: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2017)

Pharmacogenetics and adverse drug reactions
-н: Ferner, R, зэрэг
Хэвлэсэн: (2010)

An agenda for research on adverse drug reactions.
-н: Aronson, J
Хэвлэсэн: (2007)

Adverse drug reactions--no farewell to harms.
-н: Aronson, J
Хэвлэсэн: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
-н: Aronson, J
Хэвлэсэн: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
-н: Edwards, I, зэрэг
Хэвлэсэн: (2000)

Adverse drug reactions: keeping up to date.
-н: Aronson, J, зэрэг
Хэвлэсэн: (2002)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
-н: Aronson, J
Хэвлэсэн: (2017)

Paradoxical reactions: Under-recognized adverse effects of drugs?
-н: Hauben, M, зэрэг
Хэвлэсэн: (2006)

National differences in publishing papers on adverse drug reactions.
-н: Ferner, R, зэрэг
Хэвлэсэн: (2005)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
-н: Aronson, J
Хэвлэсэн: (2013)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
-н: Loke, Y, зэрэг
Хэвлэсэн: (2006)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
-н: Onakpoya, IJ, зэрэг
Хэвлэсэн: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
-н: Aronson, Jeffrey K.
Хэвлэсэн: (2006)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
-н: Aronson, J
Хэвлэсэн: (2012)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2018)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
-н: Talbot, J, зэрэг
Хэвлэсэн: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
-н: Talbot, J, зэрэг
Хэвлэсэн: (2012)

Joining the DoTS: new approach to classifying adverse drug reactions.
-н: Aronson, J, зэрэг
Хэвлэсэн: (2003)

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine
-н: Chun-Bing Chen
Хэвлэсэн: (2023-01-01)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
-н: Smith, C, зэрэг
Хэвлэсэн: (1996)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
-н: Aronson, J
Хэвлэсэн: (2005)

Adverse Drug Reactions of Cardiovascular Classes of Medicines—Data for Bulgarian Population
-н: Zornitsa Mitkova, зэрэг
Хэвлэсэн: (2024-09-01)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
-н: Talbot, J. C. C., зэрэг
Хэвлэсэн: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
-н: McDowell, SE, зэрэг
Хэвлэсэн: (2013)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
-н: Aronson, J, зэрэг
Хэвлэсэн: (2010)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
-н: Derry, S, зэрэг
Хэвлэсэн: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
-н: Derry, S, зэрэг
Хэвлэсэн: (2001)

Lorcaserin in obesity: minimal benefits and ill-defined harms
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2019)

Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review
-н: E. K. Nezhurina, зэрэг
Хэвлэсэн: (2024-12-01)

Health risks of unknown medicines: evidence from adverse drug reactions in Laos
-н: Caillet, C, зэрэг
Хэвлэсэн: (2016)

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines
-н: M. V. Zhuravleva, зэрэг
Хэвлэсэн: (2018-02-01)

Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies
-н: Shanshan Liu, зэрэг
Хэвлэсэн: (2023-12-01)

Nonsteroidal anti-inflammatory drugs’ adverse drug reactions: 10 years of national database data
-н: G. I. Syraeva, зэрэг
Хэвлэсэн: (2022-02-01)

Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
-н: Huadong Ke, зэрэг
Хэвлэсэн: (2024-10-01)